Microsoft word - sedo-g203.doc

edo-G203
HD Lithium Complex Grease

Yours’ Maintenance Solution
New formulated & multi purpose EP grease, offers superior
Available packing:
extreme-pressure protection. It prevents metal to metal seizure under high-laod conditions and shearing forces without using heavy metals or other environmentally • Resists pounding out under pressure • Retains consistency with increasing temperatures • Remains in place without softening or flowing • 60 lb. Timken rating • 500 k.g. four ball E.P. Weld load • Thermally stable • Good low-temperature pumpability • Good adhesion properties • Highly water resistant • Dropping point over 500ºF (260ºC). • Mechanically stable • Special additives prevent rust and corrosion • Extreme-pressure and high-load carrying capacity. • Temperatures -20 ºF to 400 ºF (-29 ºC to 204 ºC) Applications: It can be use in any possible industry as EP solution such as: • Anti-friction bearings • Oven conveyors • Electric motor bearings • Steel mill roller bearing • Crusher bearings • Construction and agricultural equipment at both high and low speeds • Wet or dry conditions • Automotive
MATERIAL SAFETY DATA SHEET
edo-G203
SECTION 1: PRODUCT IDENTIFICATION
materialien Gmbh
Product Name: HD Lithium Complex Grease
SECTION 2: COMPOSITION/INFORMATION ON INGREDIANTS

OSHA,PEL TLV
Petroleum Grease / Oil
Calcium Complex Soap
Corrosion Inhibition

SECTION 3: HAZARD IDENTIFICATION
Routes of entry: (x) skin ( ) eyes ( ) inhalation ( ) ingestion
Health Hazards:
This product is practically non toxic and non-irritating. However as with any petroleum product, avoid
prolonged or repeated skin contact.

SECTION 4: FIRST AID

Skin: Wash with soap and water, using nail brush. Pay particular attention to finger nails and open wounds.
Eyes: Flush eye with water for 15 minutes. Lifting the eyelids. If irritation persists consult a physician.
Ingestion: If ingested this product is not expected to cause an acute reaction. This product contains petroleum oil; Do not
induce vomiting, because the oil may be aspirated into the lungs. Consult the physician.
Inhalation: Not likely under normal conditions of use. If using in high temperature applications where thermal
decomposition is likely. Use a local exhaust to remove fumes. If dizziness or irritation occurs, seek fresh air.
SECTION 5: FIRE FIGHTING MEASURES
Flash Point and Method Used: 480˚F, C.O.C
Flammable Limits: LEL:
N/D UEL: N/D
Extinguishing Media:
Foam,CO2, dry chemical.
Special Fire Fighting Procedures: This compound will not burn unless it is pre-heated. Water fog may be used to cool the
containers but do not spray directly into large containers of burning liquids as frothing may occur. Wear “N.I.O.S.H”
approved organic vapor respirator.
Unusual Fire and Explosion Hazards: Dense smoke and noxious or toxic fumes may be generated in a fire. Fire fighters
should wear a self contained breathing apparatus.
SECTION 6: ACCIDENTAL RELEASE MEASURES

Spill/Leakage Procedures
: The viscous nature of this product makes spills unlikely. Scoop up the material and return to its
original container, or use an oil absorbent material and dispose of properly.
SECTION 7: HANDLING & STORAGE

Precautions to be taken in handling and storage: Store in closed containers away from intense heat or open flames.
Other Precautions: Do not transfer to unmarked containers. Keep away from children.


SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION


Respiratory Protection:
Normally not required. If this product is being used in high temperature application where the
product “SMOKES” use a local exhaust or ventilate the area to maintain the air quality or use a “N.I.O.S.H” approved
organic vapor respirator.
Protective Gloves: Normally not required. If prolonged or repeated skin contact is expected use a latex or neoprene glove.
Eye Protection : Safety glasses are recommended.
Work / Hygienic Practices: Use good standard practices when using this material. Do not eat or smoke while using and
thoroughly wash with soap and water, using a nail brush after using.
SECTION 9: PHYSICAL & CHEMICAL REACTIVITY

Boiling Point: >600ºF
Solubility in water: Nil
Melting Point: 500ºF
Reactivity in water: None
Vapor Pressure: No Data
Specific Gravity: 0.9
Evaporation Rate: 0
Percent Volatile: 0
Appearance and Odor: Green Grease, Petroleum like odor

SECTION 10: STABILITY AND REACTIVITY

Stability: (x) stable ( ) unstable
Conditions To Avoid: None reasonable foreseen.
Incompatibility: Strong oxidizing agent.
Hazardous Decomposition Products: The thermal decomposition products are highly dependent upon the combustion
conditions. Noxious or toxic fumes may be generated. Some of which may be toxic or irritating.
Hazardous Polymerization: Will not occur
SECTION 11: TOXICOLOGICAL INFORMATION

See section 2 for additional information and exposure limits.
SECTION 12: ECOLOGICAL INFORMATION
No additional information is available. This product is not expected to bioaccumulate.
SECTION 13: DISPOSAL CONSIDERATION

Waste Disposal: Disposal of in a responsible manner. Follow local, state and federal guidelines. Do not discharge into
sewers or waterways. Incineration is the preferred method of disposal.
SECTION 14: OTHER INFORMATION
The information contained herein is based on data considered accurate, however, no warranty is expressed or implied regarding the accuracy of the data or the results obtained from the use of his product. Therefore, because the product may be used conditions beyond our control. We assume no liability for its use.

Source: http://www.jayasukses.com.my/product/pdf/Sedo-G203.pdf

stroke.med.kyushu-u.ac.jp

19th European Stroke Conference, Barcelona,Effect of cilostazol for progressive stroke. 19th European Stroke Conference, Barcelona,deterioration in the acute phase of ischemicKoga M, Endo K, Sakai N, Yamagami H,Furui E, Matsumoto Y, Shiokawa Y,Yoshimura S, Okada Y, Hyogo T,Characteristics of acute stroke patients withmajor artery occlusion who did not receiveToyoda K, Joint research group f

Hp122-03-review (07p).p65

Drug interactions with boceprevir and telaprevir. CONCISE REVIEW A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients Kyle J. Wilby,* Erica D. Greanya,† Jo-Ann E. Ford,‡ Eric M. Yoshida,§ Nilufar Partovi||* BSP, ACPR, Doctor of Pharmacy Candidate, Faculty of Pharmaceutical Sciences,The University of British Columbia, Vancouver,

Copyright © 2008-2018 All About Drugs